Health
Sinovac – Phase I/II trial findings support use of CoronaVac vaccine in older individuals – Fintech Zoom
Sinovac – Phase I/II trial findings support use of CoronaVac vaccine in older individuals –
Sinovac – Phase I/II trial findings support use of CoronaVac vaccine in older individualsResearchers in China have reported phase I/II clinical trial findings showing that the vaccine candidate CoronaVac is well tolerated among older individuals and effectively generates antibody responses against severe acute respiratory syndrome coronavirus 2 (SARs-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).
CoronaVac is an inactivated SARS-CoV-2 vaccine developed by Chinese pharmaceutical…
-
General17 hours agoCoalition seeks to rebuild ties with Indian community
-
Noosa News20 hours agoOver $50K raised for Noosa’s Oz Bayldon after brain aneurysm
-
Business16 hours agoHow to retire in your 50s with ASX shares
-
Noosa News18 hours agoNational Drought Forum convenes in SA to put policy under scrutiny